Skip to main content
SpringerLink
Log in

The cost of outpatient epoetin and IV iron therapy for anaemia in patients with heart failure (HF) exceeds that of the resulting savings from reduced hospitalisations,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Choy CK, Spencer AP, Nappi JM.Prevalence of anemia in clinic patients with heart failure and cost analysis of epoetin treatment. Pharmacotherapy 27: 707-714, No. 5, May 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The cost of outpatient epoetin and IV iron therapy for anaemia in patients with heart failure (HF) exceeds that of the resulting savings from reduced hospitalisations,. Pharmacoecon. Outcomes News 532, 7 (2007). https://doi.org/10.2165/00151234-200705320-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705320-00013

Keywords

Search

Navigation